Psychological Group Treatment in Adults With Attention Deficit Hyperactivity Disorder: Development of a Short Cognitive -Behavioral Program
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ADHD
- Sponsor
- Hospital Vall d'Hebron
- Enrollment
- 90
- Primary Endpoint
- Change in the Clinical Global Impression - Severity (CGI-S)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that begins in childhood and can persist throughout adolescence and adulthood. ADHD affects persistently about 5% of children and adolescents and about 2.5% of adults worldwide. The cognitive behavioral therapy (CBT) has proven to be effective in significantly reducing ADHD-symptoms, maintaining the effects during follow-up.
The aim of this study is to develop and validate a psychological treatment program for adult ADHD-patients consisting of six sessions based on Cognitive Behavioural Therapy (CBT) and to study the effectiveness of the developed program in short and long term.
A total of 90 patients will be randomized to two treatment groups (1:1). One group will receive 12 sessions of CBT and the other group six sessions of brief CBT.
It is expected that the short-term effectiveness of a CBT psychological treatment program of six group sessions will be the same as the response to the CBT psychological treatment program of twelve group sessions in adult ADHD-patients with stable drug treatment.
Investigators
Josep Antoni Ramos-Quiroga
Head of Psychiatry Department
Hospital Vall d'Hebron
Eligibility Criteria
Inclusion Criteria
- •patient with ADHD
- •ADHD rating scale\>=24
- •stable pharmacological treatment
Exclusion Criteria
- •Bipolar Dissorder, Schizophrenia, Psicotic Disorders, Substance Abuse Disorder, Personality Disorders
- •Suicidity Ideation
- •Serious Organic desease
- •Participate in other Psychological Treatment during the study
Outcomes
Primary Outcomes
Change in the Clinical Global Impression - Severity (CGI-S)
Time Frame: In the 6 sessions group: at 6 weeks, at 12 weeks and at 24 weeks.In 12 session group: at 12 weeks, at 24 weeks and at 36 weeks.
Change in the ADHD-Rating Scale (ADHD-RS)
Time Frame: In the 6 sessions group: at 6 weeks, at 12 weeks and at 24 weeks.In 12 session group: at 12 weeks, at 24 weeks and at 36 weeks.
The ADHD-RS is a 18-items scale self-report version for assessing symptoms for ADHD DSM-IV. It consists of a subscale of inattention (IN, 9-items), another of hyperactivity/impulsivity (H / I, 9-items) and the total (TOT, 18-items). The interviewees are asked about the frequency of the symptoms over the past 6 months. Each item is scored from 0 to 3 points, and the highest scores indicates more severe symptomatology of ADHD.
Secondary Outcomes
- To assess the Health status(at Baseline)
- Change in the Beck Depression Inventory (BDI-II)(In the 6 sessions group: at 6 weeks, at 12 weeks and at 24 weeks.In 12 session group: at 12 weeks, at 24 weeks and at 36 weeks.)
- Change in the Functioning Assessment Short Test (FAST)(In the 6 sessions group: at 6 weeks, at 12 weeks and at 24 weeks.In 12 session group: at 12 weeks, at 24 weeks and at 36 weeks.)
- Change in the State-Trait Anxiety Inventory (STAI)(In the 6 sessions group: at 6 weeks, at 12 weeks and at 24 weeks.In 12 session group: at 12 weeks, at 24 weeks and at 36 weeks.)
- Change in the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)(In the 6 sessions group: at 6 weeks, at 12 weeks and at 24 weeks.In 12 session group: at 12 weeks, at 24 weeks and at 36 weeks.)
- To assess the severity of ADHD symptons(at Baseline)
- To assess the ADHD symptons at childhood(at Baseline)